Effects of a new cardiotonic agent, MDL-17,043, on myocardial contractility and left ventricular performance in congestive heart failure
- 1 July 1985
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 110 (1), 91-96
- https://doi.org/10.1016/0002-8703(85)90520-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying diseaseJournal of the American College of Cardiology, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983
- Variable clinical response to long-term angiotensin inhibition in severe heart failure: Demonstration of additive benefits of alpha-receptor blockadeAmerican Heart Journal, 1982
- Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043Journal of Cardiovascular Pharmacology, 1982
- Cardiovascular Properties of a New Cardiotonic AgentJournal of Cardiovascular Pharmacology, 1982
- Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.Circulation, 1981
- Oral amrinone in refractory congestive heart failureThe American Journal of Cardiology, 1980
- Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failureThe American Journal of Cardiology, 1980
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978